The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...

The REACT-AF trial began in July 2023 and is led by researchers at Johns Hopkins Medicine. Randomized patients (half of the ...

or AFib, in people who had electronic devices implanted in their chests to help monitor and regulate their heartbeats, the ...

Adding an extra hour every week of physical activity may lower the chance of developing the most common type of irregular heartbeat (arrythmia) by 11 percent, a new study shows.

Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...

Thanks to a clinical trial at Allegheny General Hospital, Schiebel, 73, has gotten his wish. The trial uses an Apple smartwatch to monitor episodes of AFib, a heart rhythm disorder that can lead to ...

Fourth Frontier has achieved a crucial milestone with the FDA's clearance of the Frontier X Plus, a single-lead ECG monitor. Positioned to enhance heart health monitoring, this wearable device ...

SAN ANTONIO — Most of us know that as we age we become more and more prone to medical ailments. But one ailment in particular may be becoming more common. We Verify. We've heard that as a ...

Fourth Frontier, a medical technology company based out of New York and Bangalore, announced the 510(k) clearance of the ...

Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy.